EMA committee recommends marketing approval for Novartis oral Fabhalta to treat adults living with C3 glomerulopathy: Basel Monday, March 3, 2025, 10:00 Hrs [IST] Novartis announc ...
Pharma GMP and Quality Management 2025 to be held in Mumbai on April 24: Our Bureau, Mumbai Monday, March 3, 2025, 09:00 Hrs [IST] The pharmaceutical industry is underg ...
DCGI stresses on govt’s commitment to foster digital transformation & capacity-building programmes for MSMEs: Shardul Nautiyal, Mumbai Monday, March 3, 2025, 08:00 Hrs [IST] The ...
India’s VC & PE firms see single specialty healthcare as untapped potential for investment: Nandita Vijayasimha, Bengaluru Monday, March 3, 2025, 08:00 Hrs [IST] Venture capital ...
DCC recommends upgradation of guidelines related to samples of spurious, NSQ drugs: Gireesh Babu, New Delhi Monday, March 3, 2025, 08:00 Hrs [IST] The Drugs Consultative Committee ...
US FDA approves first human milk-based fortifier for infants to support growth and recovery following surgery for gastroschisis: Duarte, California Saturday, March 1, 2025, 16:00 ...
MYndspan & MEGIN partner to make magnetoencephalography brain scans more accessible: London Saturday, March 1, 2025, 15:00 Hrs [IST] MYndspan, a pioneer in consumer brain health t ...
Kangpu Biopharma receives China NMPA’s IND approval for KPG-818 to treat relapsed/refractory multiple myeloma: Hefei, China Saturday, March 1, 2025, 14:00 Hrs [IST] Kangpu Bioph ...